309 related articles for article (PubMed ID: 19538112)
21. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
Read RC; Baxter D; Chadwick DR; Faust SN; Finn A; Gordon SB; Heath PT; Lewis DJ; Pollard AJ; Turner DP; Bazaz R; Ganguli A; Havelock T; Neal KR; Okike IO; Morales-Aza B; Patel K; Snape MD; Williams J; Gilchrist S; Gray SJ; Maiden MC; Toneatto D; Wang H; McCarthy M; Dull PM; Borrow R
Lancet; 2014 Dec; 384(9960):2123-31. PubMed ID: 25145775
[TBL] [Abstract][Full Text] [Related]
22. Global epidemiology of meningococcal disease and vaccine efficacy.
Pollard AJ
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S274-9. PubMed ID: 15597069
[TBL] [Abstract][Full Text] [Related]
23. Editorial commentary: fifteen years of protection by meningococcal C conjugate vaccines: lessons from disease surveillance.
Maiden MC; MacLennan JM
Clin Infect Dis; 2014 Nov; 59(9):1222-4. PubMed ID: 25069870
[No Abstract] [Full Text] [Related]
24. Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination.
Pérez-Breva L; Abad-Torreblanca R; Martínez-Beneito MÁ; Puig-Barberà J; Alemán-Sánchez S; Morant-Talamante N; Sastre-Cantón M; Vázquez-Moreno JA; Díez-Domingo J
Vaccine; 2017 May; 35(22):2949-2954. PubMed ID: 28438407
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.
Trotter CL; Andrews NJ; Kaczmarski EB; Miller E; Ramsay ME
Lancet; 2004 Jul 24-30; 364(9431):365-7. PubMed ID: 15276396
[TBL] [Abstract][Full Text] [Related]
26. A critical appraisal of the recommendations for the use of meningococcal conjugate vaccines.
Sáfadi MA; Berezin EN; Oselka GW
J Pediatr (Rio J); 2012 May; 88(3):195-202. PubMed ID: 22622596
[TBL] [Abstract][Full Text] [Related]
27. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
Carr JP; MacLennan JM; Plested E; Bratcher HB; Harrison OB; Aley PK; Bray JE; Camara S; Rodrigues CMC; Davis K; Bartolf A; Baxter D; Cameron JC; Cunningham R; Faust SN; Fidler K; Gowda R; Heath PT; Hughes S; Khajuria S; Orr D; Raman M; Smith A; Turner DPJ; Whittaker E; Williams CJ; Zipitis CS; Pollard AJ; Oliver J; Morales-Aza B; Lekshmi A; Clark SA; Borrow R; Christensen H; Trotter C; Finn A; Maiden MC; Snape MD;
Clin Microbiol Infect; 2022 Dec; 28(12):1649.e1-1649.e8. PubMed ID: 35840033
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.
Stoof SP; van Ravenhorst MB; van Rooijen DM; de Voer RM; van der Klis FRM; Boland GJ; Sanders EAM; Berbers GAM; Teunis PF
Clin Vaccine Immunol; 2017 Feb; 24(2):. PubMed ID: 27881489
[TBL] [Abstract][Full Text] [Related]
29. Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
Nunes AM; Ribeiro GS; Ferreira ÍE; Moura AR; Felzemburgh RD; de Lemos AP; Reis MG; de Moraes JC; Campos LC
PLoS One; 2016; 11(11):e0166475. PubMed ID: 27861618
[TBL] [Abstract][Full Text] [Related]
30. Meningococcal carriage in young adults six years after meningococcal C conjugate (MCC) vaccine catch-up campaign in Salvador, Brazil.
Ferreira VM; Ferreira ÍE; Chang HY; Nunes AMPB; Topaz N; Pimentel ER; Moura ARSS; Ribeiro GS; Feitosa CA; Reis MG; Wang X; Campos LC
Vaccine; 2020 Mar; 38(14):2995-3002. PubMed ID: 32115294
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.
Borrow R; Andrews N; Findlow H; Waight P; Southern J; Crowley-Luke A; Stapley L; England A; Findlow J; Miller E
Clin Vaccine Immunol; 2010 Jan; 17(1):154-9. PubMed ID: 19906895
[TBL] [Abstract][Full Text] [Related]
32. Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.
Buckwalter CM; Currie EG; Tsang RSW; Gray-Owen SD
J Infect Dis; 2017 May; 215(10):1590-1598. PubMed ID: 28368526
[TBL] [Abstract][Full Text] [Related]
33. Evolving meningococcal immunization strategies.
Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
[TBL] [Abstract][Full Text] [Related]
34. Protecting the herd: the remarkable effectiveness of the bacterial meningitis polysaccharide-protein conjugate vaccines in altering transmission dynamics.
Stephens DS
Trans Am Clin Climatol Assoc; 2011; 122():115-23. PubMed ID: 21686214
[TBL] [Abstract][Full Text] [Related]
35. 'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents.
Carr J; Plested E; Aley P; Camara S; Davis K; MacLennan JM; Gray S; Faust SN; Borrow R; Christensen H; Trotter C; Maiden MCJ; Finn A; Snape MD;
BMJ Open; 2020 Oct; 10(10):e037358. PubMed ID: 33093030
[TBL] [Abstract][Full Text] [Related]
36. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
[TBL] [Abstract][Full Text] [Related]
37. Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.
Souza AR; Maruyama CM; Sáfadi MA; Lopes MH; Azevedo RS; Findlow H; Bai X; Borrow R; Weckx LY
Vaccine; 2016 Aug; 34(36):4327-34. PubMed ID: 27395566
[TBL] [Abstract][Full Text] [Related]
38. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C.
Fernández S; Arreaza L; Santiago I; Malvar A; Berrón S; Vazquez JA; Hervada X
J Med Microbiol; 2003 Jan; 52(Pt 1):75-77. PubMed ID: 12488569
[TBL] [Abstract][Full Text] [Related]
39. Limited Impact of Adolescent Meningococcal ACWY Vaccination on Neisseria meningitidis Serogroup W Carriage in University Students.
Oldfield NJ; Green LR; Parkhill J; Bayliss CD; Turner DPJ
J Infect Dis; 2018 Jan; 217(4):608-616. PubMed ID: 29155998
[TBL] [Abstract][Full Text] [Related]
40. Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.
Marshall HS; McMillan M; Koehler AP; Lawrence A; Sullivan TR; MacLennan JM; Maiden MCJ; Ladhani SN; Ramsay ME; Trotter C; Borrow R; Finn A; Kahler CM; Whelan J; Vadivelu K; Richmond P
N Engl J Med; 2020 Jan; 382(4):318-327. PubMed ID: 31971677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
